VOLUME-PRO niVOLUMab in the rEal world in patients with squamous cell carcinoma of the head & neck (SCCHN) – Patient Reported Outcomes (PRO). BMS-NIV-2020-01

ESTUDIO POSAUTORIZACION COMERCIAL